Media stories about Dextera Surgical (NASDAQ:DXTR) have trended positive recently, Accern Sentiment Analysis reports. The research firm rates the sentiment of press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Dextera Surgical earned a news sentiment score of 0.29 on Accern’s scale. Accern also gave news headlines about the medical instruments supplier an impact score of 44.7639065657849 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Shares of Dextera Surgical (NASDAQ DXTR) remained flat at $$0.04 during trading hours on Wednesday. The company’s stock had a trading volume of 598,611 shares, compared to its average volume of 2,210,000. The stock has a market capitalization of $2.89, a P/E ratio of -0.02 and a beta of -1.35. Dextera Surgical has a 1-year low of $0.04 and a 1-year high of $2.33.

Dextera Surgical (NASDAQ:DXTR) last issued its quarterly earnings data on Thursday, November 9th. The medical instruments supplier reported ($0.09) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.07) by ($0.02). The company had revenue of $0.69 million for the quarter, compared to analysts’ expectations of $0.62 million. equities analysts expect that Dextera Surgical will post -0.27 earnings per share for the current fiscal year.

Separately, Zacks Investment Research cut shares of Dextera Surgical from a “hold” rating to a “strong sell” rating in a report on Tuesday, September 12th.

COPYRIGHT VIOLATION NOTICE: “Positive Press Coverage Somewhat Unlikely to Impact Dextera Surgical (DXTR) Share Price” was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece can be read at https://www.thecerbatgem.com/2018/01/10/positive-press-coverage-somewhat-unlikely-to-impact-dextera-surgical-dxtr-share-price.html.

Dextera Surgical Company Profile

Dextera Surgical Inc, formerly Cardica, Inc, designs and manufactures stapling devices that enable the advancement of minimally invasive surgical procedures. The Company is engaged in commercializing and developing its MicroCutter 5/80 stapler based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons.

Insider Buying and Selling by Quarter for Dextera Surgical (NASDAQ:DXTR)

Receive News & Ratings for Dextera Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dextera Surgical and related companies with MarketBeat.com's FREE daily email newsletter.